Membrane-bound CD40 ligand on T cells from mice injected with lipopolysaccharide accelerates lipopolysaccharide-induced osteoclastogenesis

Journal of Periodontal Research

Volumn 46, Issue 4, 2011, Pages 464-474

  Yokoyama, M ^a   Ukai, T ^a   Ayon Haro, E R ^a   Kishimoto, T ^a   Yoshinaga, Y ^a   Hara, Y ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Lipopolysaccharide; Membrane bound CD40 ligand; Osteoclastogenesis; T cells

Indexed keywords

ANTIBODY; CD40 LIGAND; DIAGNOSTIC AGENT; LIPOPOLYSACCHARIDE; OSTEOCLAST DIFFERENTIATION FACTOR; RECOMBINANT PROTEIN; TNFSF11 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ALVEOLAR BONE LOSS; ANIMAL; ARTICLE; BONE MARROW CELL; CELL COMMUNICATION; CELL SEPARATION; COCULTURE; COMPARATIVE STUDY; DRUG EFFECT; ESCHERICHIA COLI; FLOW CYTOMETRY; INSTITUTE FOR CANCER RESEARCH MOUSE; LYMPHOCYTE ACTIVATION; MACROPHAGE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; OSTEOCLAST; PATHOLOGY; T LYMPHOCYTE; TIME;

ALVEOLAR BONE LOSS; ANIMALS; ANTIBODIES; BONE MARROW CELLS; CD40 LIGAND; CELL COMMUNICATION; CELL SEPARATION; COCULTURE TECHNIQUES; ESCHERICHIA COLI; FLOW CYTOMETRY; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED ICR; MICE, INBRED STRAINS; MICE, SCID; OSTEOCLASTS; RANK LIGAND; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959589173     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2011.01362.x     Document Type: Article

References (38)

1. Wilson M. Biological activities of lipopolysaccharides from oral bacteria and their relevance to the pathogenesis of chronic periodontitis. Sci Prog 1995;78:19-34.
2. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie TM, Martin JT. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999;20:345-357.
3. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007;7:292-304.
4. Itoh K, Uagawa N, Kobayashi K et al. Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J Immunol 2003;170:3688-3695.
5. Li X, Udagawa N, Takami M, Sato N, Kobayashi Y, Takahashi N. p38 Mitogen-activated protein kinase is crucially involved in osteoclast differentiation but not in cytokine production, phagocytosis, or dendritic cell differentiation of bone marrow macrophages. Endocrinology 2003;144:4999-5005.
6. Nason R, Jung JY, Chole RA. Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis. J Assoc Res Otolaryngol 2009;10:151-160.
7. Islam S, Hassan F, Tunurkhuu G et al. Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells. Biochem Biophys Res Commun 2007;360:346-351.
8. Kotake S, Nanke Y, Mogi M et al. IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL. Eur J Immunol 2005;35:3353-3363.
9. Kong YY, Feige U, Sarosi I et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999;402:304-309.
10. Kanamaru F, ExIwai H, Ikeda T, Nakajima A, Ishikawa I, Azuma M. Expression of membrane-bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells. Immunol Lett 2004;94:239-246.
11. Ozaki Y, Ukai T, Yamaguchi M et al. Locally administered T cells from mice immunized with lipopolysaccharide (LPS) accelerate LPS-induced bone resorption. Bone 2009;44:1169-1176.
12. Ukai T, Yumoto H, Gibson CF III, Genco AC. Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires Toll-like receptor 2-dependent tumor necrosis factor-alpha production. Infect Immun 2008;76:812-819.
13. Sato Y, Mukai K, Watanabe S, Goto M, Shimosato Y. The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol 1986;125:431-435.
14. Kozuka Y, Ozaki Y, Ukai T, Kaneko T, Hara Y. B cells play an important role in lipopolysaccharide-induced bone resorption. Calcif Tissue Int 2006;78:125-132.
15. Moriyama H, Ukai T, Hara Y. Interferon-gamma production changes in parallel with bacterial lipopolysaccharide induced bone resorption in mice: an immunohistometrical study. Calcif Tissue Int 2002;71:53-58.
16. Akiyoshi W, Takahashi T, Kanno T et al. Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid. J Biol Chem 2005;19:18967-18972.
17. Akiyoshi W, Takahashi T, Kanno T et al. Heparin inhibits osteoclastic differentiation and function. J Cell Biochem 2008;103:1707-1717.
18. Naito K. Aldehydic components of Cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation. Bioorg Med Chem 2008;16:9176-9183.
19. Tani-Ishii N, Penninger JM, Matsumoto G, Teranaka T, Umemoto T. The role of LFA-1 in osteoclast development induced by co-cultures of mouse bone marrow cells and MC3T3-G2/PA6 cells. J Periodontal Res 2002;37:184-191.
20. Yang J, Park JO, Lee YJ, Jung HM, Woo KM, Choi Y. The 4-1BB ligand and 4-1BB expressed on osteoclast precursors enhance RANKL-induced osteoclastogenesis via bi-directional signaling. Eur J Immunol 2008;38:1598-1609.
21. Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000;67:2-17.
22. Grewal SI, Flavell AR. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998;16:111-135.
23. Kadono Y, Okada F, Perchonock C et al. Strength of TRAF6 signalling determines osteoclastogenesis. EMBO Rep 2005;6:171-176.
24. Gohda J, Akiyama T, Koga T, Takyanagi H, Tanaka S, Inoue J. RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis. EMBO J 2005;24:790-799.
25. Kobayashi K, Takahashi N, Jimi E et al. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 2000;191:275-285.
26. Orima K, Yamazaki K, Aoyagi T, Hara K. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue. Clin Exp Immunol 1999;115:153-160.
27. Matthies K, Newman J, Hodzic A, Wingett D. Differential regulation of soluble and membrane CD40L proteins in T cells. Cell Immunol 2006;241:47-58.
28. Skov S, Bonyhadi M, Odum N, Ledbetter JA. IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells. J Immunol 2000;164:3500-3505.
29. Fayen DJ. Multiple cytokines sharing the common receptor gamma chain can induce CD154/CD40 ligand expression by human CD4+ T lymphocytes via a cyclosporin A-resistant pathway. Immunology 2001;104:299-306.
30. Darveau RP, Pham TT, Lemley K et al. Porphromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect Immun 2004;72:5041-5051.
31. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998;9:248-266.
32. Kawai TB, Matsuyama T, Hosokawa Y et al. T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 2006;169:987-998.
33. + hematopoietic cells. J Immunol 2009;183:4859-4870.
34. Hirohata S. Human Th1 responses driven by IL-12 are associated with enhanced expression of CD40 ligand. Clin Exp Immunol 1998;115:78-85.
35. McDyer J, Li Z, John S et al. IL-2 receptor blockade inhibits late, but not early, IFN-γ and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-γ production. J Immunol 2002;169:2736-2746.
36. + T cells isolated from inflamed human gingival tissues. Clin Exp Immunol 1996;103:422-428.
37. Takeichi O, Haber J, Kawai T et al. Cytokine profiles of T-lymphocytes from gingival tissues with pathological pocketing. J Dent Res 2000;79:1548-1555.
38. Ukai T, Mori Y, Onoyama M, Hara Y. Immunohistological study of interferon-gamma-and interleukin-4-bearing cells in human periodontitis gingival. Arch Oral Biol 2001;46:901-908.